van Varsseveld, Otis C.
Raasveld, Floris V.
Liu, Wen-Chih
McCarty, Justin
Hundepool, Caroline A.
Zuidam, J. Michiel
Valerio, Ian L.
Eberlin, Kyle R. https://orcid.org/0000-0003-4427-2588
Article History
Received: 15 February 2025
Accepted: 17 April 2025
First Online: 6 June 2025
Declarations
:
: This study involved human participants and was conducted in accordance with ethical standards. Ethics approval was obtained from the Institutional Review Board (IRB) of Massachusetts General Hospital (MGH) (#2020P003555). Informed consent was obtained for all contacted participants.
: Not applicable. This manuscript does not contain any individual person’s data in any form (including individual details, images, or videos). Publication licenses for artwork created with BioRender are provided.
: I.V. is a consultant for AxoGen Inc., Checkpoint Surgical Inc., and Integra Lifesciences Inc. K.E. is a consultant for AxoGen Inc., Checkpoint Surgical Inc., Integra Lifesciences Inc., Tissium, Tulavi Therapeutics Inc., and Biocircuit. O.V., F.R., W.L., J.M., C.H., and M.Z. have none.